Daily Roundup

PRO.ASX 8CO.ASX RMD.ASX CXZ.ASX BOT.ASX

Prophecy and Securonix Forge Global Reseller Agreement

Prophecy International Holdings Ltd has struck a major deal, signing a 3-year global reseller agreement with US-based SIEM leader Securonix, Inc. This strategic partnership will see Securonix resell Prophecy's Snare cybersecurity solution to its customers and partners, enhancing their endpoint data collection and visibility.

8CO Reports Record Q2 SaaS Revenue

In another standout performance, 8common Limited (ASX: 8CO) has reported record transaction and recurring SaaS revenue of $1.2 million for Q2 FY25, up 9% on the previous corresponding period. The fintech company also saw strong cash receipts from operations of $2.3 million and an annualised recurring revenue of c.$5.0 million.

ResMed Delivers Robust Q2 Results

Medical device manufacturer ResMed Inc. announced impressive Q2 FY2025 results, with revenue growing 10% year-over-year and operating profit up 52%. The company also reported $309 million in operating cash flow and announced the launch of the Kontor Head Strap, a premium accessory for the Apple Vision Pro.

Connexion Mobility Sees 43% Profit Growth in H1 FY25

Automotive fleet and rental management software provider Connexion Mobility Ltd reported a 15% increase in revenue and a 43% rise in profit after tax for the first half of FY25. The company's working capital position also improved, with a surplus of US$1.89 million as at 31 December 2024.

Botanix Pharmaceuticals Launches Sofdra™ in the US

Botanix Pharmaceuticals Ltd has released its Q4 2024 report, highlighting the successful launch of its lead product Sofdra™ for primary axillary hyperhidrosis. The company issued its first Sofdra prescriptions in December, with a 100% refill rate achieved in January, and is now rolling out a full commercial launch with its field sales force.